Neutrophils and B lymphocytes in ANCA-associated vasculitis

被引:9
|
作者
Witko-Sarsat, Veronique [1 ,2 ]
Daniel, Soizic [1 ,2 ]
Noel, Laure-Helene [1 ,2 ]
Mouthon, Luc [3 ]
机构
[1] Hop Necker Enfants Malad, INSERM, U845, F-75015 Paris, France
[2] Univ Paris 05, F-75015 Paris, France
[3] Cochin Hosp, UPRES EA 4058, Paris, France
关键词
ANCA; neutrophils; proteinase; 3; myeloperoxidase; B cells; review; ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; WEGENERS-GRANULOMATOSIS; MEMBRANE PROTEINASE-3; SURFACE EXPRESSION; GENE-EXPRESSION; STIMULATOR; GLOMERULONEPHRITIS; ANTIBODIES; APOPTOSIS;
D O I
10.1111/j.1600-0463.2009.02473.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The pathogenesis of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is unknown but is most consistent with a primary role for neutrophils in the acute injury. Thus, neutrophils are cardinal cells in the pathophysiological process in AAV because they are both effector cells responsible for endothelial damage and targets of autoimmunity. In addition, because of their capacity to synthesize a wide variety of cytokines and chemokines, neutrophils can be considered as important modulators of the inflammatory and potentially of the autoimmune process. ANCA directed against two main autoantigens, namely proteinase 3 and myeloperoxidase, are likely to play a modulatory role in the inflammatory process. Interestingly, neutrophils are an important source of lymphocyte stimulator (BLy), a cytokine that plays a fundamental role in B-cell physiology, including differentiation, proliferation and immunoglobulin production. The issue of B-cell activation and/or dysregulation in vasculitis will be discussed.
引用
收藏
页码:27 / 31
页数:5
相关论文
共 50 条
  • [1] Targeting B lymphocytes as therapy for ANCA-Associated vasculitis
    Golbin, Jason M.
    Specks, Ulrich
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2007, 33 (04) : 741 - +
  • [2] Neutrophils in ANCA-associated vasculitis: Still under investigation
    Witko-Sarsat, Veronique
    [J]. PRESSE MEDICALE, 2013, 42 (04): : 595 - 597
  • [3] Neutrophils in ANCA-associated vasculitis: Mechanisms and implications for management
    Ge, Shangqing
    Zhu, Xingyu
    Xu, Qinyao
    Wang, Junyan
    An, Cheng
    Hu, Ying
    Yang, Fan
    Wang, Xinyi
    Yang, Yipin
    Chen, Shuwen
    Jin, Ruimin
    Li, Haiyan
    Peng, Xinchen
    Liu, Yue
    Xu, Junnan
    Zhu, Minhui
    Shuai, Zongwen
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [4] ANCA-Associated Vasculitis
    Sharma, Purva
    Zonozi, Reza
    Geetha, Duvuru
    [J]. ADVANCES IN KIDNEY DISEASE AND HEALTH, 2024, 31 (03): : 194 - 205
  • [5] ANCA-associated vasculitis
    Herrera-Darias, Sandro
    Guillen-Chirinos, Gilsy
    Gomez-Cerquera, Juan Manuel
    [J]. MEDICINA CLINICA, 2023, 160 (10): : 467 - 467
  • [6] ANCA-associated vasculitis
    A. Richard Kitching
    Hans-Joachim Anders
    Neil Basu
    Elisabeth Brouwer
    Jennifer Gordon
    David R. Jayne
    Joyce Kullman
    Paul A. Lyons
    Peter A. Merkel
    Caroline O. S. Savage
    Ulrich Specks
    Renate Kain
    [J]. Nature Reviews Disease Primers, 6
  • [7] Dying neutrophils in ANCA-associated vasculitis: Good or bad guys?
    Kallenberg, CGM
    [J]. KIDNEY INTERNATIONAL, 2002, 61 (02) : 758 - 759
  • [8] ANCA-associated vasculitis
    Krasselt, Marco L.
    Holle, Julia U.
    [J]. INNERE MEDIZIN, 2022, 63 (09): : 947 - 960
  • [9] ANCA-associated vasculitis
    Holle, J. U.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 (05): : 445 - 456
  • [10] ANCA-associated vasculitis
    不详
    [J]. Nature Reviews Disease Primers, 6 (1)